2012Unpublished venueRequires access

Influence of introducing SLC22A18 gene on the radiosensitivity of human glioma U251 cells

Zhi-an Zhu

Open publisher page 0 citations

Abstract

Objective:To study the effect of SLC22A18 gene on the radiosensitivity of human glioma U251 cells.Methods:The eukaryotic expression plasmid pIRES2-EGFP-SLC22A18 was constructed and introduced by Lipofectamine 2000 into cultured U251 cells.SLC22A18 mRNA and protein expression was detected by RT-PCR and Western blot assay.U251 cells were divided into 4 groups:control group,transfected group,radiation group and combined treatmemt group.The number of colonies was assessed using a clonogenic assay.The cell growth inhibitition and apoptosis was assessed by MTT and flow cytometry.The tumor growth inhibition effect was further studied in vivo.The pIRES2-SLC22A18 was injected iniratumorally into established subcutaneous U251 glioma in nude mice mediated by Lipofectamine 2000.Results:The transfection of SLC22A18 gene into U251 cells was confirmed by RT-PCR and Western blot assay.The number of colonies was assessed using a clonogenic assay in the transfected group(60.6 ± 5.2).That induced by radiation was decreased [(30.0 ± 3.6),(13.0 ± 3.0),(4.0 ± 1.0) ]with the increase of radiation doses(3,6,9 Gy).MTT showed that SLC22A18 gene by itself induced strong inhibition effect on the growth of U251 cells [inhibition rate,IR(80.12 ± 5.75) ].The killing effect of radiation by itself on U251 cells was not strong [IR(17.05 ± 4.24) %,(17.34 ± 1.62) %,(18.71 ± 4.59) %]and increased with the increase of radiation doses(3,6,9 Gy).When combined treatment of SLC22A18 gene transfection and radiation was used,that was significantly increased [IR(81.45 ± 5.32) %,(90.45 ± 1.65) %,(92.62 ± 2.12) %].The apoptotic rate of U251 cells induced by SLC22A18 gene transfection was 17.68%.That induced by radiation was increased(4.64%,4.87%,5.42%) with the increase of radiation doses(3,6,9 Gy).The apoptotic rate was also significantly increased(18.42%,21.48%,23.92%) after combined treatment of SLC22A18 and radiation with different doses(3,6,9 Gy).The antitumor enhancement ratio of SLC22A18 at 6 Gy was 1.81 for U251 cells in vivo.Conclusion:Introduction of SLC22A18 gene into human glioma U251 cells can increase their radiosensitivity.

About this research paper

What this paper is about

Objective:To study the effect of SLC22A18 gene on the radiosensitivity of human glioma U251 cells.Methods:The eukaryotic expression plasmid pIRES2-EGFP-SLC22A18 was constructed and introduced by Lipofectamine 2000 into cultured U251 cells.SLC22A18 mRNA and protein expression was detected by RT-PCR and Western blot assay.U251 cells were divided into 4 groups:control group,transfected group,radiation group and combined treatmemt group.The number of colonies was assessed using a clonogenic assay.The cell growth inhibitition and apoptosis was assessed by MTT and flow cytometry.The tumor growth inhibition effect was further studied in vivo.The pIRES2-SLC22A18 was injected iniratumorally into established subcutaneous U251 glioma in nude mice mediated by Lipofectamine 2000.Results:The transfection of SLC22A18 gene into U251 cells was confirmed by RT-PCR and Western blot assay.The number of colonies was assessed using a clonogenic assay in the transfected group(60.6 ± 5.2).That induced by radiation was decreased [(30.0 ± 3.6),(13.0 ± 3.0),(4.0 ± 1.0) ]with the increase of radiation doses(3,6,9 Gy).MTT showed that SLC22A18 gene by itself induced strong inhibition effect on the growth of U251 cells [inhibition rate,IR(80.12 ± 5.75) ].The killing effect of radiation by itself on U251 cells was not strong [IR(17.05 ± 4.24) %,(17.34 ± 1.62) %,(18.71 ± 4.59) %]and increased with the increase of radiation doses(3,6,9 Gy).When combined treatment of SLC22A18 gene transfection and radiation was used,that was significantly increased [IR(81.45 ± 5.32) %,(90.45 ± 1.65) %,(92.62 ± 2.12) %].The apoptotic rate of U251 cells induced by SLC22A18 gene transfection was 17.68%.That induced by radiation was increased(4.64%,4.87%,5.42%) with the increase of radiation doses(3,6,9 Gy).The apoptotic rate was also significantly increased(18.42%,21.48%,23.92%) after combined treatment of SLC22A18 and radiation with different doses(3,6,9 Gy).The antitumor enhancement ratio of SLC22A18 at 6 Gy was 1.81 for U251 cells in vivo.Conclusion:Introduction of SLC22A18 gene into human glioma U251 cells can increase their radiosensitivity.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To study the effect of SLC22A18 gene on the radiosensitivity of human glioma U251 cells.Methods:The eukaryotic expression plasmid pIRES2-EGFP-SLC22A18 was constructed and introduced by Lipofectamine 2000 into cultured U251 cells.SLC22A18 mRNA and protein expression was detected by RT-PCR and Western blot assay.U251 cells were divided into 4 groups:control group,transfected group,radiation group and combined treatmemt group.The number of colonies was assessed using a clonogenic assay.The cell growth inhibitition and apoptosis was assessed by MTT and flow cytometry.The tumor growth inhibition effect was further studied in vivo.The pIRES2-SLC22A18 was injected iniratumorally into established subcutaneous U251 glioma in nude mice mediated by Lipofectamine 2000.Results:The transfection of SLC22A18 gene into U251 cells was confirmed by RT-PCR and Western blot assay.The number of colonies was assessed using a clonogenic assay in the transfected group(60.6 ± 5.2).That induced by radiation was decreased [(30.0 ± 3.6),(13.0 ± 3.0),(4.0 ± 1.0) ]with the increase of radiation doses(3,6,9 Gy).MTT showed that SLC22A18 gene by itself induced strong inhibition effect on the growth of U251 cells [inhibition rate,IR(80.12 ± 5.75) ].The killing effect of radiation by itself on U251 cells was not strong [IR(17.05 ± 4.24) %,(17.34 ± 1.62) %,(18.71 ± 4.59) %]and increased with the increase of radiation doses(3,6,9 Gy).When combined treatment of SLC22A18 gene transfection and radiation was used,that was significantly increased [IR(81.45 ± 5.32) %,(90.45 ± 1.65) %,(92.62 ± 2.12) %].The apoptotic rate of U251 cells induced by SLC22A18 gene transfection was 17.68%.That induced by radiation was increased(4.64%,4.87%,5.42%) with the increase of radiation doses(3,6,9 Gy).The apoptotic rate was also significantly increased(18.42%,21.48%,23.92%) after combined treatment of SLC22A18 and radiation with different doses(3,6,9 Gy).The antitumor enhancement ratio of SLC22A18 at 6 Gy was 1.81 for U251 cells in vivo.Conclusion:Introduction of SLC22A18 gene into human glioma U251 cells can increase their radiosensitivity.

Key concepts: Clonogenic assay, Lipofectamine, Radiosensitivity, Transfection, MTT assay, Molecular biology, Apoptosis, Glioma

Related papers

Back to paper searchBrowse research topicsOriginal source
Influence of introducing SLC22A18 gene on the radiosensitivity of human glioma U251 cells — Research Paper | ScholarLens